Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic

N C Gutiérrez1, J M Hernández, J L García

  • 1Servicio de Hematología, Hospital Universitario de Salamanca, Spain.

Leukemia
|May 23, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

Blood cancer journal·2024
Same author

Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation.

Leukemia supplements·2016
Same author

PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma.

Leukemia·2015
Same author

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations.

Leukemia·2014
Same author

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Leukemia·2013

Genomic analysis reveals distinct chromosomal imbalances between multiple myeloma (MM) and plasma cell leukemia (PCL). These differences, particularly in chromosomal losses, may help differentiate these plasma cell disorders.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Multiple myeloma (MM) and plasma cell leukemia (PCL) are distinct plasma cell neoplasms.
  • Understanding their genomic differences is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate and compare the genomic alterations in MM and PCL using comparative genomic hybridization (CGH).

Main Methods:

  • CGH analysis was performed on 30 patients (25 MM, 5 PCL).
  • Plasma cell enrichment using immunomagnetic beads was employed in cases with low plasma cell counts.

Main Results:

  • DNA copy number changes were detected in 96% of MM and 100% of PCL patients.
  • Recurrent gains in MM included chromosomes 15q, 11q, 3q, 9q, and 1q.

Related Experiment Videos

  • PCL patients uniquely showed gains in 1q and significantly more frequent losses on chromosomes 13q and 16, as well as losses on 2q and 6p.

    • Conclusions:

    • CGH analysis identified significant differences in chromosomal imbalances between MM and PCL.
    • These genomic disparities may contribute to the distinct clinical behaviors of MM and PCL.